Clinical Trial Update: Phase 2 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults With Atopic Dermatitis [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the efficacy and safety of tralokinumab in adults with atopic dermatitis has completed, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Tralokinumab (tralokinumab)

Snippet

Sponsor: MedImmune LLC | Conditions: Atopic Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2017-06-07